Hologic Acquisition by Blackstone and TPG
Hologic (Nasdaq: HOLX) has agreed to be acquired by funds managed by private equity firms Blackstone and TPG.
The deal values Hologic at up to $79 per share, representing an enterprise value of up to $18.3 billion.
- Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash.
- A non-tradable contingent value right (CVR) will provide up to $3 per share in two payments of up to $1.50 each.
- CVRs are contingent on certain global revenue goals for Hologic's Breast Health business in 2026 and 2027.
Shares of HOLX rose 4% to $74.75 apiece following the news.
The purchase price marks a premium of approximately 46% to Hologic’s closing price on May 23, 2025.
Author's summary: Hologic to be acquired for up to $18.3B.